BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 35868048)

  • 1. Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma.
    Xu Y; Li Y; Lu Y; Wang W; Lian Z; Wu Z; Li B; Yu D
    J Hepatocell Carcinoma; 2023; 10():2197-2209. PubMed ID: 38090626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis.
    Cai H; Shao B; Zhou Y; Chen Z
    Oncol Lett; 2020 Nov; 20(5):232. PubMed ID: 32968454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and targeting of metastatic biomarkers for hepatocellular carcinoma therapeutics using small molecules library of curcumin analogues.
    Gupta A; Choudhary P; Singh S
    Mol Divers; 2024 Apr; ():. PubMed ID: 38689175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making.
    Dhanasekaran R; Suzuki H; Lemaitre L; Kubota N; Hoshida Y
    Hepatology; 2023 Jun; ():. PubMed ID: 37300379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving-pattern analysis of transient and long-term biomarkers for cancers: Hepatocellular carcinoma as a case.
    Wang Y; Cai Y; Miao Y
    Interdiscip Sci; 2015 Feb; ():. PubMed ID: 25663115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal instability drives immunosuppression and metastatic dissemination.
    Vitale I; Galassi C; Galluzzi L
    Cell Res; 2024 Jan; 34(1):7-8. PubMed ID: 37739994
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel biomarkers and strategies for HCC diagnosis and care.
    Wang AE; Leven EA; Grinspan LT; Villanueva A
    Clin Liver Dis (Hoboken); 2024; 23(1):e0152. PubMed ID: 38707238
    [No Abstract]   [Full Text] [Related]  

  • 8. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
    Chen W; Tang D; Ou M; Dai Y
    DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic molecular markers in hepatocellular carcinoma.
    Mínguez B; Lachenmayer A
    Dis Markers; 2011; 31(3):181-90. PubMed ID: 22045404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy.
    Hu Y; Tang C; Zhu W; Ye H; Lin Y; Wang R; Zhou T; Wen S; Yang J; Fang C
    Comput Biol Med; 2022 Sep; 148():105896. PubMed ID: 35868048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
    Chen J; Chen X; Li T; Wang L; Lin G
    Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.